Announce Date | 07/30/2025 |
EPS Normalized Actual | $1.44 (Beat by $0.05) |
EPS GAAP Actual | $1.44 (Beat by $0.05) |
Revenue Actual | $5.29B |
Revenue Surprise | Beat by $5290M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.37167 |
EPS GAAP Estimate | $1.37167 |
Revenue Estimate | $5.448106324B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 6.08 | 10.59 | 5.93224 | 6.18224 | 2 |
Dec 2028 | 5.64488 | 11.41 | 5.52469 | 5.70899 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.41 | 0.03333 | 5.29B | -17.37% | -158.11M |
FQ1 2025 (Mar 2025) | 0.64 | 0.64 | 5.259B | 100% | 5259M |
FQ4 2024 (Dec 2024) | 1.79 | 1.79 | 5.106B | 1.61% | 5106M |
FQ3 2024 (Sep 2024) | 1.33 | 1.33 | 6.259B | 100% | 6259M |
FQ2 2024 (Jun 2024) | 2.21 | 2.21 | 6.209B | 100% | 6209M |
FQ1 2024 (Mar 2024) | 1.21 | 1.21 | 0B | NAN% | 0M |
FQ4 2023 (Dec 2023) | 1.16 | 1.16 | 5.024B | -1.17% | 5024M |
FQ4 2022 (Dec 2022) | 0 | 0 | 5.083B | 100% | 5083M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.37167
Consensus Revenue Estimates
5.448106324B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.38129 | -- | 1.34828 | 1.40309 | 7 |
FQ3 2027 (Sep 2027) | 1.55397 | -- | 1.55397 | 1.55397 | 1 |
FQ2 2027 (Jun 2027) | 1.4461 | -- | 1.4461 | 1.4461 | 1 |
FQ1 2027 (Mar 2027) | 1.32117 | -- | 1.2896 | 1.34202 | 7 |
FQ4 2026 (Oct 2026) | 1.43184 | -- | 1.41942 | 1.44236 | 3 |
FQ3 2026 (Jul 2026) | 1.40485 | -- | 1.39266 | 1.41518 | 4 |
FQ2 2026 (Jun 2026) | 1.40485 | -0.37 | 1.37194 | 1.42703 | 4 |
FQ1 2026 (Mar 2026) | 1.26861 | 49.55 | 1.23889 | 1.28864 | 5 |
FQ4 2025 (Oct 2025) | 1.37886 | -29.82 | 1.3669 | 1.38899 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 5.25B | -- | 5.16B | 5.32B | 6 |
FQ3 2027 (Sep 2027) | 5.45B | -- | 5.45B | 5.45B | 2 |
FQ2 2027 (Jun 2027) | 5.24B | -- | 5.24B | 5.24B | 2 |
FQ1 2027 (Mar 2027) | 4.62B | -- | 4.53B | 4.67B | 4 |
FQ4 2026 (Oct 2026) | 5.54B | -- | 5.5B | 5.57B | 2 |
FQ3 2026 (Jul 2026) | 5.51B | -- | 5.47B | 5.54B | 2 |
FQ2 2026 (Jun 2026) | 5.51B | 3.92 | 5.41B | 5.57B | 4 |
FQ1 2026 (Mar 2026) | 4.87B | -8.02 | 4.78B | 4.93B | 4 |
FQ4 2025 (Oct 2025) | 5.41B | 5.66 | 5.38B | 5.44B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
6
Revenue # of Misses
1
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.37667 | 1.41 | 0.03333 | 2.36% |
FQ1 2025 (Mar 2025) | 0.64 | 0.64 | 100% | |
FQ4 2024 (Dec 2024) | 1.79 | 1.79 | 100% | |
FQ3 2024 (Sep 2024) | 1.33 | 1.33 | 100% | |
FQ2 2024 (Jun 2024) | 2.21 | 2.21 | 100% | |
FQ1 2024 (Mar 2024) | 1.21 | 1.21 | 100% | |
FQ4 2023 (Dec 2023) | 1.16 | 1.16 | 100% | |
FQ4 2022 (Dec 2022) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $5.45B | $5.29B | $-158.11M | -2.99% |
FQ1 2025 (Mar 2025) | $0B | $5.26B | $5259M | 100% |
FQ4 2024 (Dec 2024) | $0B | $5.11B | $5106M | 100% |
FQ3 2024 (Sep 2024) | $0B | $6.26B | $6259M | 100% |
FQ2 2024 (Jun 2024) | $0B | $6.21B | $6209M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
FQ4 2023 (Dec 2023) | $0B | $5.02B | $5024M | 100% |
FQ4 2022 (Dec 2022) | $0B | $5.08B | $5083M | 100% |